| Attribute |
Value |
| 52 Week Change |
1.5675676 |
| Address1 |
Building C14 |
| Address2 |
4th Floor No. 218, Xinghu Street Suzhou Industrial Park |
| All Time High |
31.83 |
| All Time Low |
0.9 |
| Ask |
3.8 |
| Ask Size |
1 |
| Average Analyst Rating |
1.3 - Strong Buy |
| Average Daily Volume10 Day |
440,630 |
| Average Daily Volume3 Month |
278,101 |
| Average Volume |
278,101 |
| Average Volume10Days |
440,630 |
| Beta |
0.587 |
| Bid |
3.8 |
| Bid Size |
1 |
| Book Value |
0.746 |
| City |
Suzhou |
| Country |
China |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
3.8 |
| Current Ratio |
3.074 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,774,915,200 |
| Day High |
3.9977 |
| Day Low |
3.73 |
| Debt To Equity |
12.068 |
| Display Name |
Adagene |
| Earnings Timestamp End |
1,753,704,000 |
| Earnings Timestamp Start |
1,753,268,340 |
| Ebitda |
-20,999,432 |
| Ebitda Margins |
-2.73754 |
| Enterprise To Ebitda |
-8.198 |
| Enterprise To Revenue |
22.442 |
| Enterprise Value |
172,150,448 |
| Eps Current Year |
-0.51 |
| Eps Forward |
-0.52 |
| Eps Trailing Twelve Months |
-0.38 |
| Esg Populated |
0 |
| Exchange |
NGM |
| Exchange Data Delayed By |
0 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
3.558 |
| Fifty Day Average Change |
0.24199986 |
| Fifty Day Average Change Percent |
0.0680157 |
| Fifty Two Week Change Percent |
156.75676 |
| Fifty Two Week High |
4.75 |
| Fifty Two Week High Change |
-0.95000005 |
| Fifty Two Week High Change Percent |
-0.2 |
| Fifty Two Week Low |
1.3 |
| Fifty Two Week Low Change |
2.5 |
| Fifty Two Week Low Change Percent |
1.923077 |
| Fifty Two Week Range |
1.3 - 4.75 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
1,612,881,000,000 |
| Float Shares |
41,416,178 |
| Forward Eps |
-0.52 |
| Forward P E |
-7.3076925 |
| Free Cashflow |
-10,250,600 |
| Full Exchange Name |
NasdaqGM |
| Full Time Employees |
128 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Gross Margins |
1.0 |
| Gross Profits |
7,670,902 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.11068 |
| Held Percent Institutions |
0.20504999 |
| Implied Shares Outstanding |
66,072,595 |
| Industry |
Biotechnology |
| Industry Disp |
Biotechnology |
| Industry Key |
biotechnology |
| Ipo Expected Date |
2,021-02-09 |
| Is Earnings Date Estimate |
1 |
| Language |
en-US |
| Last Fiscal Year End |
1,767,139,200 |
| Long Business Summary |
Adagene Inc., a clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancers in the People's Republic of China. Its lead product candidate is the ADG126, a masked fully-human anti-CTLA-4 mAb which is in phase 1b/2 clinical development for the treatment of cancer. The company also develops ADG116, a fully human anti-CTLA-4 antibody generated using NEObody technology, which is in phase 1b/2 clinical trials to treat advanced/metastatic solid tumors; ADG206, which is in phase 1 clinical development to treat advanced metastatic solid tumors; ADG104, anti-PD-L1 monoclonal antibody which is in phase 2 clinical development; and ADG125, a novel anti-CSF-1R mAb which is in Phase 2 clinical development. In addition, it is developing ADG138, a HER2xCD3 POWERbody which is in pre clinical trial to treat low expressing tumors, as well as resistant/refractory tumors; ADG152, a CD20xCD3 POWERbody which is in preclincal trial to treat off-tumor toxicities; ADG153, a masked anti-CD47 IgG1 SAFEbody, wihx is in preclinical trial for the treatment of hematologic and solid tumor; and CD28 T-cell engagers, an anti-CD28 bispecific POWERbody TCEs to treat solid tumors. Adagene Inc. was incorporated in 2011 and is headquartered in Suzhou, China. |
| Long Name |
Adagene Inc. |
| Market |
us_market |
| Market Cap |
251,075,856 |
| Market State |
PRE |
| Max Age |
86,400 |
| Message Board Id |
finmb_118162960 |
| Most Recent Quarter |
1,767,139,200 |
| Net Income To Common |
-17,609,412 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
251,075,858 |
| Number Of Analyst Opinions |
5 |
| Open |
3.89 |
| Operating Cashflow |
-15,657,450 |
| Operating Margins |
-0.74959 |
| Payout Ratio |
0.0 |
| Phone |
86 512 8777 3632 |
| Previous Close |
3.89 |
| Price Eps Current Year |
-7.4509807 |
| Price Hint |
4 |
| Price To Book |
5.093834 |
| Price To Sales Trailing12 Months |
32.73094 |
| Profit Margins |
-2.29561 |
| Quick Ratio |
3.014 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
strong_buy |
| Recommendation Mean |
1.33333 |
| Region |
US |
| Regular Market Change |
-0.0900002 |
| Regular Market Change Percent |
-2.31363 |
| Regular Market Day High |
3.9977 |
| Regular Market Day Low |
3.73 |
| Regular Market Day Range |
3.73 - 3.9977 |
| Regular Market Open |
3.89 |
| Regular Market Previous Close |
3.89 |
| Regular Market Price |
3.8 |
| Regular Market Time |
1,776,801,601 |
| Regular Market Volume |
295,051 |
| Return On Assets |
-0.15996 |
| Return On Equity |
-0.34386003 |
| Revenue Growth |
73.328 |
| Revenue Per Share |
0.163 |
| Sand P52 Week Change |
0.3140242 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Shares Outstanding |
66,072,594 |
| Shares Percent Shares Out |
0.0015 |
| Shares Short |
71,244 |
| Shares Short Previous Month Date |
1,772,150,400 |
| Shares Short Prior Month |
51,190 |
| Short Name |
Adagene Inc. |
| Short Percent Of Float |
0.0019 |
| Short Ratio |
0.34 |
| Source Interval |
15 |
| Symbol |
ADAG |
| Target High Price |
14.0 |
| Target Low Price |
7.0 |
| Target Mean Price |
9.4 |
| Target Median Price |
8.0 |
| Total Cash |
75,844,096 |
| Total Cash Per Share |
1.28 |
| Total Debt |
6,263,222 |
| Total Revenue |
7,670,902 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.0 |
| Trailing Annual Dividend Yield |
0.0 |
| Trailing Eps |
-0.38 |
| Trailing Peg Ratio |
None |
| Triggerable |
1 |
| Two Hundred Day Average |
2.37944 |
| Two Hundred Day Average Change |
1.4205599 |
| Two Hundred Day Average Change Percent |
0.59701437 |
| Type Disp |
Equity |
| Volume |
295,051 |
| Website |
https://www.adagene.com |
| Zip |
215,123 |